Back to Agenda
Session 8 Breakout 1 - Substantial Evidence
Session Chair(s)
Kristina Vlaovic, MPH
Vice President, Regulatory, Safety and Pharmacovigilance
HALOZYME Inc., United States
Speaker(s)
Panelist
Sue E. Duvall, MBA, MPA, RN
GoProMo LLC, United States
Panelist
Lynette Hopkinson
Vertex Pharmaceuticals Incorporated, United States
Vice President, Commercial Regulatory Affairs, Global Regulatory Affairs
Panelist
Leah Palmer, PharmD
United States
Consultant, Regulatory Promotion
Have an account?